AASLD Interview | Professor Fengmin Lu: Exploring Interferon Cure Advantages in Chronic Hepatitis B, Delving into Mechanisms to Guide New Drug Development

AASLD Interview | Professor Fengmin Lu: Exploring Interferon Cure Advantages in Chronic Hepatitis B, Delving into Mechanisms to Guide New Drug Development

2023.12.25
At the just-concluded Annual Summit of Hepatology, the American Association for the Study of Liver Diseases (AASLD2023), Professor Fengmin Lu's team from Peking University presented three contributions (1 oral presentation and 2 posters), focusing on the mechanisms related to chronic HBV infection. Their research revealed populations benefiting from interferon therapy in chronic Hepatitis B (CHB) and explored potential new targets for curing. "Hepatology Digest" has specially invited Professor Fengmin Lu to interpret the research findings, their significance and implications for future scientific research or clinical practice, and to envision the prospects for functional cure among the CHB population in our country.
AASLD Interview | Professor Vincent Wai-Sun Wong: Global Differences and New Advances in the Diagnosis and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

AASLD Interview | Professor Vincent Wai-Sun Wong: Global Differences and New Advances in the Diagnosis and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

2023.12.22
In his research, Vincent Wai-Sun Wong performs multidisciplinary study on Steatohepatitis and Fatty liver. Fatty liver is frequently linked to Disease in his study. His studies link Steatohepatitis with Disease. His Gastroenterology study frequently links to adjacent areas such as Transient elastography. Transient elastography and Biopsy are commonly linked in his work. He integrates Biopsy and Fibrosis in his studies. Vincent Wai-Sun Wong conducts interdisciplinary study in the fields of Fibrosis and Inflammation through his research. His work blends Inflammation and Liver disease studies together. In his study, he carries out multidisciplinary Liver disease and Cirrhosis research.
AASLD Hot Topic | Dr. Zhihong Liu of Southern Hospital: Hepatitis B Expanded Treatment, Simplified Treatment, and Progress in Functional Cure Drugs

AASLD Hot Topic | Dr. Zhihong Liu of Southern Hospital: Hepatitis B Expanded Treatment, Simplified Treatment, and Progress in Functional Cure Drugs

2023.12.22
The AASLD (American Association for the Study of Liver Diseases) 2023 conference was held in Boston, USA, from November 10th to 14th, marking a significant event in the field of hepatology. Hepatology Digest's reporting team was fortunate to invite Dr. Zhihong Liu from the Department of Infectious Diseases and Hepatology at Southern Hospital of Southern Medical University to share insights from the AASLD and discuss the work presented by his team at the conference, along with their learning experiences.
AASLD Hot Topic | Dr. Zhihong Liu of Southern Hospital: Hepatitis B Expanded Treatment, Simplified Treatment, and Progress in Functional Cure Drugs Deserve Attention

AASLD Hot Topic | Dr. Zhihong Liu of Southern Hospital: Hepatitis B Expanded Treatment, Simplified Treatment, and Progress in Functional Cure Drugs Deserve Attention

2023.12.20
The AASLD (American Association for the Study of Liver Diseases) 2023 conference was held in Boston, USA, from November 10th to 14th, marking a significant event in the field of hepatology. Hepatology Digest's reporting team was fortunate to invite Dr. Zhihong Liu from the Department of Infectious Diseases and Hepatology at Southern Hospital of Southern Medical University to share insights from the AASLD and discuss the work presented by his team at the conference, along with their learning experiences.
AASLD Interview | Professor Wai-Kay Seto’s Team: Presentation of Five Achievements in Predicting Clinical Cure of Hepatitis B and Post-operative Recurrence of Liver Cancer, and Commentary on Liver Disease Research Trends

AASLD Interview | Professor Wai-Kay Seto’s Team: Presentation of Five Achievements in Predicting Clinical Cure of Hepatitis B and Post-operative Recurrence of Liver Cancer, and Commentary on Liver Disease Research Trends

2023.12.20
The 74th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2023) has just concluded in Boston, USA. The team led by Professor Wai-Kay Seto from the University of Hong Kong focused on five research outcomes in the areas of mother-to-child transmission blockage and clinical cure of Hepatitis B, clearance of Hepatitis C, post-operative recurrence of liver cancer, and post-liver transplant management. These outcomes were presented at the meeting, with two of them being shared in the form of oral presentations. Professor Seto's team has been committed to the clinical management and scientific research of chronic liver diseases, achieving fruitful results. Hepatology Digest invited the team's principal researchers to interpret the findings and comment on the trends in liver disease research and share their experiences at the conference. The interview video is shared below.
AASLD Interview丨Professor Jeffrey V. Lazarus: Clinical Management, Research Priorities, and Future Action Plans for MASLD

AASLD Interview丨Professor Jeffrey V. Lazarus: Clinical Management, Research Priorities, and Future Action Plans for MASLD

2023.12.14
The 2023 American Association for the Study of Liver Diseases (AASLD 2023) recently concluded in Boston, USA. metabolic dysfunction-associated steatotic liver disease (MASLD) was a key topic at the conference. In the "Healthy Liver, Healthy Lives" session, experts discussed how to reverse the global MASLD trend and what actions to take to address MASLD management challenges. Dr. Jeffrey V. Lazarus, head of the Health Systems Research Group at ISGlobal in Barcelona, Spain, attended the meeting and gave an interview to "Hepatology Digest" afterward. The interview video and the transcript in both English and Chinese are compiled below.